152 related articles for article (PubMed ID: 31762817)
1. Lin28b is involved in curcumin-reversed paclitaxel chemoresistance and associated with poor prognosis in hepatocellular carcinoma.
Tian N; Shangguan W; Zhou Z; Yao Y; Fan C; Cai L
J Cancer; 2019; 10(24):6074-6087. PubMed ID: 31762817
[TBL] [Abstract][Full Text] [Related]
2. Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma.
Wang K; Duan C; Zou X; Song Y; Li W; Xiao L; Peng J; Yao L; Long Q; Liu L
Oncol Lett; 2018 Apr; 15(4):4303-4313. PubMed ID: 29556287
[TBL] [Abstract][Full Text] [Related]
3. Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent.
You ML; Chen YJ; Chong QY; Wu MM; Pandey V; Chen RM; Liu L; Ma L; Wu ZS; Zhu T; Lobie PE
Oncotarget; 2017 Jun; 8(24):39323-39344. PubMed ID: 28445151
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
[TBL] [Abstract][Full Text] [Related]
5. Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Komatsu H; Iguchi T; Masuda T; Hirata H; Ueda M; Kidogami S; Ogawa Y; Sato K; Hu Q; Nambara S; Saito T; Sakimura S; Uchi R; Ito S; Eguchi H; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2017 Mar; 24(3):850-859. PubMed ID: 27770342
[TBL] [Abstract][Full Text] [Related]
6. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
7. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
[TBL] [Abstract][Full Text] [Related]
8. Aurora-A promotes chemoresistance in hepatocelluar carcinoma by targeting NF-kappaB/microRNA-21/PTEN signaling pathway.
Zhang K; Chen J; Chen D; Huang J; Feng B; Han S; Chen Y; Song H; De W; Zhu Z; Wang R; Chen L
Oncotarget; 2014 Dec; 5(24):12916-35. PubMed ID: 25428915
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA-16 facilitates the paclitaxel resistance by targeting IKBKB via NF-κB signaling pathway in hepatocellular carcinoma.
Huang Y; Chen G; Wang Y; He R; Du J; Jiao X; Tai Q
Biochem Biophys Res Commun; 2018 Sep; 503(2):1035-1041. PubMed ID: 29935185
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer.
Hsu KF; Shen MR; Huang YF; Cheng YM; Lin SH; Chow NH; Cheng SW; Chou CY; Ho CL
Br J Cancer; 2015 Jul; 113(3):414-24. PubMed ID: 26158423
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological significance of transcription termination factor, RNA polymerase I in human liver hepatocellular carcinoma.
Komatsu H; Iguchi T; Ueda M; Nambara S; Saito T; Hirata H; Sakimura S; Takano Y; Uchi R; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Eguchi H; Doki Y; Mori M; Mimori K
Oncol Rep; 2016 Apr; 35(4):2073-80. PubMed ID: 26821084
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein upregulates Lin28A/Lin28B through Sp-1/c-Myc to enhance the proliferation of hepatoma cells.
You X; Liu F; Zhang T; Lv N; Liu Q; Shan C; Du Y; Kong G; Wang T; Ye L; Zhang X
Oncogene; 2014 Jan; 33(4):449-60. PubMed ID: 23318446
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits proliferation of hepatocellular carcinoma cells by blocking PTPN1 and PTPN11 expression.
Zhang J; Liu Y; Wang X; Wang Z; Xing E; Li J; Wang D
Oncol Lett; 2023 Jul; 26(1):307. PubMed ID: 37332329
[TBL] [Abstract][Full Text] [Related]
14. Overexpressed nuclear BAG-1 in human hepatocellular carcinoma is associated with poor prognosis and resistance to doxorubicin.
Ni W; Chen B; Zhou G; Lu C; Xiao M; Guan C; Zhang Y; He S; Shen A; Ni R
J Cell Biochem; 2013 Sep; 114(9):2120-30. PubMed ID: 23553841
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
Li Y; Ye Y; Feng B; Qi Y
J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma.
Guo Y; Chen Y; Ito H; Watanabe A; Ge X; Kodama T; Aburatani H
Gene; 2006 Dec; 384():51-61. PubMed ID: 16971064
[TBL] [Abstract][Full Text] [Related]
17. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma.
Hu B; Sun D; Sun C; Sun YF; Sun HX; Zhu QF; Yang XR; Gao YB; Tang WG; Fan J; Maitra A; Anders RA; Xu Y
Biochem Biophys Res Commun; 2015 Dec; 468(4):525-32. PubMed ID: 26482853
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of ubiquitin-conjugating enzyme E2 S overexpression in hepatocellular carcinoma.
Ma Y; Li K; Li S; Liang B; Liu Q; Mo Z
Int J Biol Macromol; 2018 Nov; 119():225-231. PubMed ID: 30041036
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA LINC01134 Promotes Hepatocellular Carcinoma Metastasis via Activating AKT1S1 and NF-κB Signaling.
Wang C; Chen Y; Chen K; Zhang L
Front Cell Dev Biol; 2020; 8():429. PubMed ID: 32656205
[TBL] [Abstract][Full Text] [Related]
20. A nuclear lncRNA Linc00839 as a Myc target to promote breast cancer chemoresistance via PI3K/AKT signaling pathway.
Chen Q; Shen H; Zhu X; Liu Y; Yang H; Chen H; Xiong S; Chi H; Xu W
Cancer Sci; 2020 Sep; 111(9):3279-3291. PubMed ID: 32619088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]